In recent weeks, the early results of a cannabis-coronavirus trial have surfaced in popular publications. But have the facts been sensationalized?
Quality management and compliance-based activities are a way of life in the cannabis testing lab, says Kim Ross.
The findings add further weight to the case for using medical cannabis as a substitute for illicit opioids.
In light of other studies that have found similar associations, the research could still have vital implications for public health approaches to cannabis legalization.
The new study suggests that such non-medical, commercial hemp oil can help treat neuropathic pain.
Women who regularly consume cannabis experience more intense cravings for the drug than their male counterparts, a study has found.
A new study of the first 400 patients to be prescribed CBD oil in New Zealand suggests that the cannabinoid may be beneficial for treating patients suffering with symptoms of non-cancer pain and mental health conditions.
Supplied by the Latin American company Khiron Life Sciences, the cannabis products will first be issued to UK doctors before being prescribed to the 20,000 patients expected to be involved in the trial.